Seres Therapeutics Inc (NAS:MCRB)
$ 0.9577 -0.09 (-8.57%) Market Cap: 145.94 Mil Enterprise Value: 298.35 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q4 2019 Seres Therapeutics Inc Earnings Call Transcript

Mar 02, 2020 / 01:30PM GMT
Release Date Price: $3.23 (+2.87%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter Seres Therapeutics Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Mr. Carlo Tanzi, Head of Investor Relation. Please go ahead, sir.

Carlo Tanzi
Seres Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, Olivia, and good morning, everyone. A press release with the company's fourth quarter 2019 financial results and the business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors and Media section of the company's website.

I'd like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, regulatory approval, the promise and potential impact of any of our microbiome therapeutics, the sufficiency of our cash and cash equivalents to fund operations and the ability of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot